Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular surface analysis in dry eye with meibomian gland dysfunction treated with preservative-free 3% diquafosol
TCTR20260417008Phase 0Not yet recruiting
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of diquafosol in dry eye syndrome (DED) and meibomian gland dysfunction (MGD), sponsored by None. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on TCTR20260417008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260417008.